EP0833835A4 - Intermediaires de proteines contre l'obesite, leur preparation et leur utilisation - Google Patents
Intermediaires de proteines contre l'obesite, leur preparation et leur utilisationInfo
- Publication number
- EP0833835A4 EP0833835A4 EP96921702A EP96921702A EP0833835A4 EP 0833835 A4 EP0833835 A4 EP 0833835A4 EP 96921702 A EP96921702 A EP 96921702A EP 96921702 A EP96921702 A EP 96921702A EP 0833835 A4 EP0833835 A4 EP 0833835A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- preparation
- obesity protein
- protein intermediates
- intermediates
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Obesity (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Child & Adolescent Psychology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45195P | 1995-06-22 | 1995-06-22 | |
US451 | 1995-06-22 | ||
PCT/US1996/010613 WO1997000886A1 (fr) | 1995-06-22 | 1996-06-20 | Intermediaires de proteines contre l'obesite, leur preparation et leur utilisation |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0833835A1 EP0833835A1 (fr) | 1998-04-08 |
EP0833835A4 true EP0833835A4 (fr) | 1999-05-26 |
Family
ID=21691591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96921702A Ceased EP0833835A4 (fr) | 1995-06-22 | 1996-06-20 | Intermediaires de proteines contre l'obesite, leur preparation et leur utilisation |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0833835A4 (fr) |
JP (1) | JPH11508134A (fr) |
AU (1) | AU6284896A (fr) |
CA (1) | CA2224867A1 (fr) |
WO (1) | WO1997000886A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2217698A1 (fr) * | 1996-12-20 | 1998-06-20 | Eli Lilly And Company | Proteines contre l'obesite |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
DE10059336A1 (de) | 2000-11-29 | 2002-06-13 | Scil Proteins Gmbh | Herstellung von rekombinantem BMP-2 |
EP2219031B1 (fr) | 2001-10-22 | 2013-04-24 | Amgen, Inc. | Utilisation de Leptine pour traiter la Lipoatrophine humaine et procédé pour déterminer une prédisposition à ce traitement |
US20120071401A1 (en) | 2009-04-10 | 2012-03-22 | Amylin Pharamaceuticals, Inc. | Amylin agonist compounds for estrogen-deficient mammals |
CA3138758A1 (fr) | 2010-09-28 | 2012-04-19 | Amylin Pharmaceuticals, Llc | Leptines hautement solubles |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994018227A2 (fr) * | 1993-02-04 | 1994-08-18 | Denzyme Aps | Procede ameliore de repliement de proteines |
WO1996005309A2 (fr) * | 1994-08-17 | 1996-02-22 | The Rockefeller University | Modulateurs de masse corporelle, proteines et acides nucleiques correspondants, et utilisations a des fins therapeutiques et diagnostiques |
WO1996027385A1 (fr) * | 1995-03-03 | 1996-09-12 | Eli Lilly And Company | Proteines contre l'obesite |
WO1996034885A2 (fr) * | 1995-05-05 | 1996-11-07 | Smithkline Beecham Plc | Fragments peptidiques biologiquement actifs de proteines ob |
WO1997006816A1 (fr) * | 1995-08-17 | 1997-02-27 | Amgen Inc. | Procedes pour diminuer ou maintenir un niveau bas de lipides dans le sang, en utilisant des compositions de proteine ob |
-
1996
- 1996-06-20 EP EP96921702A patent/EP0833835A4/fr not_active Ceased
- 1996-06-20 JP JP9503935A patent/JPH11508134A/ja active Pending
- 1996-06-20 WO PCT/US1996/010613 patent/WO1997000886A1/fr not_active Application Discontinuation
- 1996-06-20 AU AU62848/96A patent/AU6284896A/en not_active Abandoned
- 1996-06-20 CA CA 2224867 patent/CA2224867A1/fr not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994018227A2 (fr) * | 1993-02-04 | 1994-08-18 | Denzyme Aps | Procede ameliore de repliement de proteines |
WO1996005309A2 (fr) * | 1994-08-17 | 1996-02-22 | The Rockefeller University | Modulateurs de masse corporelle, proteines et acides nucleiques correspondants, et utilisations a des fins therapeutiques et diagnostiques |
WO1996027385A1 (fr) * | 1995-03-03 | 1996-09-12 | Eli Lilly And Company | Proteines contre l'obesite |
WO1996034885A2 (fr) * | 1995-05-05 | 1996-11-07 | Smithkline Beecham Plc | Fragments peptidiques biologiquement actifs de proteines ob |
WO1997006816A1 (fr) * | 1995-08-17 | 1997-02-27 | Amgen Inc. | Procedes pour diminuer ou maintenir un niveau bas de lipides dans le sang, en utilisant des compositions de proteine ob |
Non-Patent Citations (2)
Title |
---|
MURAKAMI T ET AL: "CLONING OF RAT OBESE CDNA AND ITS EXPRESSION IN OBESE RATS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 209, no. 3, 26 April 1995 (1995-04-26), pages 944 - 952, XP002003621 * |
See also references of WO9700886A1 * |
Also Published As
Publication number | Publication date |
---|---|
JPH11508134A (ja) | 1999-07-21 |
CA2224867A1 (fr) | 1997-01-09 |
WO1997000886A1 (fr) | 1997-01-09 |
EP0833835A1 (fr) | 1998-04-08 |
AU6284896A (en) | 1997-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL118469A0 (en) | Naphthalene derivatives their preparation and intermediates thereof | |
IL126811A0 (en) | Human b-cell antigens and related reagents | |
IL118059A0 (en) | Recombinant obese proteins | |
IL122215A0 (en) | Dolastatin derivatives their preparation and use | |
IL118442A0 (en) | Triazolymethyl-cyclopentanols their preparation and use | |
IL118441A0 (en) | Triazolymethyl-oxiranes their preparation and use | |
AU6288296A (en) | Novel human chemotactic cytokine | |
HK1010153A1 (en) | Recombinant human alpha-fetoprotein and uses thereof. | |
HUP9901343A3 (en) | P53 protein variants and therapeutical uses thereof | |
EP0939761A4 (fr) | Proteines secretees par la salmonelle et utilisations de ces proteines | |
GB9516059D0 (en) | Novel genes and proteins | |
NZ300198A (en) | Preparation of n-arylhydroxylamines and n-hetarylhydroxylamines | |
ZA96240B (en) | Novel peptides their preparation and use | |
IL118295A0 (en) | 3-(2- trialkylsilyloxy) ethyl-7-ethyl-1H- indoles and their preparation | |
AU4862396A (en) | Human obesity gene | |
EP0833835A4 (fr) | Intermediaires de proteines contre l'obesite, leur preparation et leur utilisation | |
AU5613498A (en) | Cerebellum and embryo specific protein | |
ZA96239B (en) | Novel peptides their preparation and use | |
IL131247A0 (en) | Cash protein its preparation and use | |
HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof | |
GB9423372D0 (en) | Proteins and their uses | |
AU4459196A (en) | Sustained-release preparation and use | |
IL122686A0 (en) | Benzylhydroxylamines their preparation and use | |
IL118444A0 (en) | Mercapto-triazolyl-silanes their preparation and use | |
ZA978220B (en) | PTX-sensitive G proteins their preparation and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971217 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL PAYMENT 971217;LT PAYMENT 971217;LV PAYMENT 971217;SI PAYMENT 971217 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19990409 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
RHK1 | Main classification (correction) |
Ipc: C07K 14/575 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20000801 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1009819 Country of ref document: HK |